<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7366108\results\search\zoonosis\results.xml">
  <result pre="as long as the COVID-19 resource centre remains active. Abstract" exact="Coronavirus disease 2019" post="(COVID-19) is an unprecedented disease caused by highly pathogenic"/>
  <result pre="changes, and trans-signaling in endothelial cells [[17], [18], [19], [20]]." exact="SARS-CoV-2 infection" post="cause final release and increase in pro-inflammatory cytokines, including"/>
  <result pre="or cells expressing ACE2 are possibly at extreme risk for" exact="SARS-CoV-2 infection." post="In COVID-19 patients with pre-existing CVD, the demise of"/>
  <result pre="patient, a moderate level of microvascular steatosis indicates that either" exact="SARS-CoV-2 infection" post="or drug used during treatment was the possible cause"/>
  <result pre="COVID-19 patients, but the predisposition of the diabetic population to" exact="SARS-CoV-2 infection" post="may not be higher as compared to healthy people."/>
  <result pre="a paucity of data to confirm that pregnant women with" exact="COVID 19" post="are more susceptible to severe pneumonia and vertical transmission"/>
  <result pre="as pneumonia and some proof of vertical maternal-fetal transmission of" exact="SARS-CoV-2 infection" post="[81]. A recent study on pediatric patients with COVID-19"/>
  <result pre="viruses, including coronaviruses Umifenovir is an antiviral treatment used for" exact="influenza infection" post="used in Russia and China. National Clinical Trial Identifier:(NCT04252885),"/>
  <result pre="Investigating the Safety and Effects of Four BNT162 Vaccines Against" exact="COVID-2019" post="in Healthy Adults Biontech RNA Pharmaceuticals GmbH Phase1 &amp;amp;II(200)"/>
  <result pre="Phase I(100) On-going NCT04299724 7. Lentiviral Minigene Vaccine (LV-SMENP) of" exact="Covid-19" post="Coronavirus; Subcutaneously Shenzhen Geno-Immune Medical Institute, Guangdong, China Phase"/>
  <result pre="Wuhan, ChinaJama32320201061106910.1001/jama.2020.1585 9WangY.WangY.ChenY.QinQ.Unique epidemiological and clinical features of the emerging" exact="2019 novel coronavirus pneumonia" post="(COVID-19) implicate special control measuresJ. Med. Virol.92202056857610.1002/jmv.2574832134116 10Di Gennaro,"/>
  <result pre="Am. Heart Assoc.92020e01621910.1161/JAHA.120.016219 46GuoY.R.CaoQ.D.HongZ.S.TanY.Y.ChenS.D.JinH.J.TanK.S.WangD.Y.YanY.The origin, transmission and clinical therapies on" exact="coronavirus disease 2019" post="(COVID-19) outbreakâ€&quot;an update on the statusMilitary Medical Research7202011010.1186/s40779-020-00240-031928528 47WuY.XuX.ChenZ.DuanJ.HashimotoK.YangL.YangC.Nervous"/>
  <result pre="treating COVID-19Current Pharmacology Reports62020567010.1007/s40495-020-00216-7 49MaoL.JinH.WangM.HuY.ChenS.HeQ.MiaoX.Neurologic manifestations of hospitalized patients with" exact="coronavirus disease 2019" post="in Wuhan, ChinaJAMA neurology202010.1001/jamaneurol.2020.1127 50XiangP.XuX.M.GaoL.L.WangH.Z.XiongH.F.LiR.H.First case of 2019 novel"/>
  <result pre="Reznikov, L. R., ... &amp;amp; McCray Jr, P. B. (2016)." exact="Middle East respiratory syndrome" post="coronavirus causes multiple organ damage and lethal disease in"/>
  <result pre="with acute respiratory distress syndromeLancet Respir. Med.8202042042210.1016/S2213-2600(20)30076-X32085846 70CheungK.S.HungI.F.ChanP.P.LungK.C.TsoE.LiuR.NgY.Y.ChuM.Y.ChungT.W.TamA.R.YipC.C.Gastrointestinal manifestations of" exact="SARS-CoV-2 infection" post="and virus load in fecal samples from the Hong"/>
  <result pre="individuals without underlying diseases in pandemic epicentersmedRxiv202010.1101/2020.04.05.20054361 85SandersJ.M.MonogueM.L.JodlowskiT.Z.CutrellJ.B.Pharmacologic treatments for" exact="coronavirus disease 2019" post="(COVID-19): a reviewJama202010.1001/jama.2020.6019 86https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-potential-covid-19-treatment. 87https://www.europeanpharmaceuticalreview.com/news/121787/glenmark-approved-to-supply-favipiravir-as-covid-19-treatment-in-india/. 88https://www.ashp.org/-/media/assets/pharmacy-practice/resourcecenters/Coronavirus/docs/ASHP-COVID-19-Evidence-Table.ashx?. 89KeithP.DayM.PerkinsL.MoyerL.HewittK.WellsA.A novel treatment"/>
 </snippets>
</snippetsTree>
